Boston Scientific Corporation (0HOY.L)
USD 105.22
(1.9%)
USD 105.22
(1.9%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.34 Billion USD | 28.45% |
| 2022 | 1.82 Billion USD | -5.1% |
| 2021 | 1.92 Billion USD | 219.8% |
| 2020 | 601 Million USD | -64.89% |
| 2019 | 1.71 Billion USD | -1.44% |
| 2018 | 1.73 Billion USD | 13.9% |
| 2017 | 1.52 Billion USD | 23.38% |
| 2016 | 1.23 Billion USD | 14.13% |
| 2015 | 1.08 Billion USD | 12.93% |
| 2014 | 959 Million USD | 5.73% |
| 2013 | 907 Million USD | -5.03% |
| 2012 | 955 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 644 Million USD | 15.41% |
| 2024 Q2 | 520 Million USD | -19.25% |
| 2024 Q3 | 718 Million USD | 29.62% |
| 2023 Q3 | 558 Million USD | 1.27% |
| 2023 Q4 | 558 Million USD | 0.0% |
| 2023 Q1 | 515 Million USD | 14.7% |
| 2023 Q2 | 551 Million USD | 6.99% |
| 2023 FY | 2.18 Billion USD | 19.57% |
| 2022 Q4 | 449 Million USD | -2.39% |
| 2022 Q2 | 477 Million USD | 4.38% |
| 2022 Q1 | 457 Million USD | 0.0% |
| 2022 FY | 1.82 Billion USD | -5.1% |
| 2022 Q3 | 460 Million USD | -3.56% |
| 2021 Q3 | 442 Million USD | -13.5% |
| 2021 FY | 1.92 Billion USD | 219.8% |
| 2021 Q1 | 366 Million USD | -42.27% |
| 2021 Q2 | 511 Million USD | 39.62% |
| 2021 Q4 | 457 Million USD | 3.39% |
| 2020 Q3 | 282 Million USD | 954.55% |
| 2020 Q4 | 634 Million USD | 124.82% |
| 2020 FY | 601 Million USD | -64.89% |
| 2020 Q1 | 246 Million USD | -50.9% |
| 2020 Q2 | -33 Million USD | -113.41% |
| 2019 Q3 | 419 Million USD | -6.26% |
| 2019 Q2 | 447 Million USD | 2.05% |
| 2019 FY | 1.71 Billion USD | -1.44% |
| 2019 Q1 | 438 Million USD | -7.98% |
| 2019 Q4 | 501 Million USD | 19.57% |
| 2018 Q3 | 397 Million USD | -6.81% |
| 2018 Q1 | 427 Million USD | -5.11% |
| 2018 Q2 | 426 Million USD | -0.23% |
| 2018 Q4 | 476 Million USD | 19.9% |
| 2018 FY | 1.73 Billion USD | 13.9% |
| 2017 Q1 | 336 Million USD | -8.45% |
| 2017 FY | 1.52 Billion USD | 23.38% |
| 2017 Q4 | 450 Million USD | 15.38% |
| 2017 Q3 | 390 Million USD | -7.58% |
| 2017 Q2 | 422 Million USD | 25.6% |
| 2016 FY | 1.23 Billion USD | 14.13% |
| 2016 Q1 | 320 Million USD | 13.07% |
| 2016 Q2 | 343 Million USD | 7.19% |
| 2016 Q3 | 363 Million USD | 5.83% |
| 2016 Q4 | 367 Million USD | 1.1% |
| 2015 Q4 | 283 Million USD | 6.79% |
| 2015 Q3 | 265 Million USD | 1.53% |
| 2015 FY | 1.08 Billion USD | 12.93% |
| 2015 Q2 | 261 Million USD | -4.74% |
| 2015 Q1 | 274 Million USD | 7.03% |
| 2014 FY | 959 Million USD | 5.73% |
| 2014 Q2 | 237 Million USD | -3.27% |
| 2014 Q4 | 256 Million USD | 12.28% |
| 2014 Q3 | 228 Million USD | -3.8% |
| 2014 Q1 | 245 Million USD | 12.39% |
| 2013 Q1 | 209 Million USD | -13.28% |
| 2013 Q3 | 228 Million USD | -9.52% |
| 2013 Q4 | 218 Million USD | -4.39% |
| 2013 FY | 907 Million USD | -5.03% |
| 2013 Q2 | 252 Million USD | 20.57% |
| 2012 Q4 | 241 Million USD | 0.0% |
| 2012 FY | 955 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 1878.058% |
| Accuray Incorporated | 504 Thousand USD | -464780.952% |
| Align Technology, Inc. | 643.33 Million USD | -264.194% |
| Elevance Health Inc. | 133.96 Billion USD | 98.251% |
| AxoGen, Inc. | -21.46 Million USD | 11016.97% |
| CVS Health Corporation | 13.74 Billion USD | 82.951% |
| Cardinal Health, Inc. | 1.24 Billion USD | -88.496% |
| Centene Corporation | 2.93 Billion USD | 20.034% |
| DaVita Inc. | 1.6 Billion USD | -46.183% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 75.662% |
| Hologic, Inc. | 970.2 Million USD | -141.497% |
| Humana Inc. | 4.01 Billion USD | 41.615% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -113.558% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -222.905% |
| Masimo Corporation | 136.5 Million USD | -1616.484% |
| McKesson Corporation | 3.9 Billion USD | 40.061% |
| Patterson Companies, Inc. | 252.92 Million USD | -826.365% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -85.658% |
| ResMed Inc. | 1.31 Billion USD | -77.514% |
| Henry Schein, Inc. | 615 Million USD | -280.976% |
| Teladoc Health, Inc. | -248.55 Million USD | 1042.656% |
| Universal Health Services, Inc. | 1.17 Billion USD | -99.34% |
| Veeva Systems Inc. | 429.33 Million USD | -445.729% |
| Baxter International Inc. | 390 Million USD | -500.769% |
| Becton, Dickinson and Company | 2.11 Billion USD | -10.99% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -32.613% |
| Danaher Corporation | 5.38 Billion USD | 56.458% |
| Stryker Corporation | 3.88 Billion USD | 39.738% |
| Medtronic plc | 5.14 Billion USD | 54.452% |